The Province is providing $195M in funding in life sciences
Darpan News Desk The Canadian Press, 02 Mar, 2022 05:03 PM
The province is providing 195-million dollars in grant funding to help attract and retain top researchers in the life sciences field.
Jobs Minister Ravi Kahlon says Michael Smith Health Research B-C will get 116-million dollars while Genome BC will get the rest in order to spur innovation.
— Brenda Bailey, MLA (@BrendaBaileyBC) March 2, 2022
Kahlon says the province wants to leverage B-C's contributions to developing and manufacturing COVID-19 vaccines towards learning how to deal with future pandemics.
He says the funding could also help advance research in a range of areas including the development of new medications, rapid diagnostic tests for diseases and clean technology.
There have been 4 new COVID-19 related deaths over a 3 day period, for a total of 1,734 deaths in British Columbia. 75.9% of all adults in B.C. and 74.1% of those 12 and older have now received their first dose of a COVID-19 vaccine.
An annual pollution charge the city’s “Climate Emergency Parking Program” proposes Vancouverites who own a 2023 or newer “high-polluting” vehicle — described as a gas-powered luxury sports car, large SUV or full-size pickup truck — would be charged $1,000 per year to get a residential parking permit.
The federal government wants a "robust" and ongoing investigation into the origins of the novel coronavirus, Health Minister Patty Hajdu said in the House of Commons Monday ahead of an expected grilling by MPs examining Canada's relationship with China.
The RCMP say a resident reported finding the squirrels in South Arm Community Park and fire crews identified the substance as 1-Octanethiol, a compound used in the production of other chemicals that can be dangerous if it's not handled correctly.
As provinces accelerate their efforts to get their populations fully vaccinated against COVID-19, some people are calling for the federal government to issue clear guidance on what people can do once they receive both shots.
A new study in England suggests the Pfizer-BioNTech and Oxford-AstraZeneca vaccines are extremely good at keeping people from ending up in the hospital with COVID-19, even after just one dose.
